Lemon Frost Gecko Emerges as Promising Natural Model for Human Cancer Research
核心洞察
A University of Nottingham-led study published in BMC Biology identifies the lemon frost leopard gecko as a novel animal model for studying cancer, with tumors appearing naturally in approximately 80% of individuals.
Whole-genome sequencing revealed recurring genetic changes in gecko tumors that affect the same genes and biological pathways implicated in human cancers.
Unlike laboratory mice that require tumor induction, lemon frost geckos develop aggressive, metastatic tumors at a relatively young age, offering a rare window into natural cancer progression.
A distinctive color variant of the leopard gecko, prized in the pet trade for its striking white-and-yellow appearance, may hold unexpected value for oncology research. A new study led by the University of Nottingham and published in BMC Biology has found that the "lemon frost" morph develops aggressive tumors in approximately 80% of individuals, and the genetic changes driving those tumors overlap significantly with pathways known to be involved in human cancers.
The lemon frost morph originated from a spontaneous genetic mutation that appeared during selective breeding in a large colony of leopard geckos. While its vivid coloration quickly attracted attention from breeders, an unfortunate pattern soon emerged: many of these geckos developed aggressive tumors that frequently metastasized to other parts of the body.
A Natural Model for Cancer Progression
Unlike traditional laboratory models such as mice, which typically require researchers to artificially trigger tumor growth, lemon frost geckos develop cancer naturally and at a relatively young age. Because these tumors often metastasize, the reptiles provide scientists with a rare opportunity to observe how cancer begins, evolves, and spreads under natural conditions.
Dr. Ylenia Chiari from the School of Life Sciences at the University of Nottingham, who led the study, explained the broader vision: "By studying why some animals are so susceptible to cancer while others are remarkably resistant, we hope to uncover the different ways species have evolved to deal with cancer. Specifically, this gecko could become an incredible model in cancer research because tumors appear naturally at a relatively early age. Together, these natural strategies could inspire new ways of preventing, detecting, and treating cancer in humans."
Genomic Insights Reveal Shared Cancer Pathways
To investigate the molecular underpinnings of the disease, the international research team employed whole-genome sequencing to compare tumor samples with healthy tissue from the same geckos. The analysis uncovered a recurring set of genetic changes across the tumors. Critically, many of the altered genes and biological processes have already been linked to cancer in humans and other animals, suggesting that findings from this reptilian model could extend well beyond veterinary medicine.
Brandon Hastings, a PhD researcher at the University of Nottingham and one of the study's authors, noted the methodological significance: "Overall, our paper demonstrates the importance of looking across the tree of life in search of answers that are needed to better understand diseases that can have a profound impact on human life, such as cancer. Methodologically, it also highlights that the variety of genomic software programs developed to analyze human cancers can be adapted to provide meaningful insights in diverse organisms."
The Value of Biodiversity in Medical Research
Among reptiles, cancer risk varies widely. Turtles and tortoises, for instance, rarely develop the disease, making the lemon frost gecko (搜索)'s extreme susceptibility all the more striking. This contrast underscores the potential value of studying both cancer-vulnerable and cancer-resistant species.
Dr. Scott Glaberman of the University of Birmingham, a collaborator on the study, emphasized the broader implications: "We often look inward to solve human problems, but every species has something to teach us. By studying both animals that are vulnerable to cancer and those that resist it, we have far greater power to understand the disease itself. This is one of the many reasons why protecting biodiversity is so important."
The international research team also included Dr. Tony Gamble of Marquette University, Dr. Robert Ossiboff of the University of Florida, and Virginia Gazziero and Dr. Giulio Caravagna of the University of Trieste. Their collective work highlights how expanding the range of animal models used in medical research—particularly species that naturally develop cancers at high rates—can complement traditional laboratory approaches and open new avenues for investigating human disease.